Home
|
About Us
|
Contact Us
Our Networks
National
International
Marketing
Domestic Marketing
International Marketing
Distribution & Logistics
Contact Us
R & D
Objectives
Products Developed
Achievements
R&D Infrastructure
Future Plans
Our Divisions
Nova Division
Ethical Division
Generic Division
Institution Division
Proposed Divisions
Why Choose Us
Our Presence
Strengths
Ranking
Awards
Production
Major Break Throughs
Products In Pipeline
Investors
Board of Directors
Board Meeting
Share Holding Patterns
Quarterly Results
Annual Reports
Voting Results
Corporate Governance >>
Code of Conduct
Live Stock in NSE
Live Stock in BSE
Transfer of shares to IEPF
Unclaimed Dividends
Unclaimed Deposit
Detailed NCLT Petition >>
Career
Work Culture
Career & Growth
Employee Benefits
HR Contact Details
Current Openings
Application Form
Media Center
Corporate Film
Corporate Brochure
Presentation
e-Newsletter
Image Gallery
Ind-Swift in News
ISL Empire 2014
CSR
Code of Fair Disclosure
T & C of Appointment
Party Transaction Policy
Risk Management Policy
Material Subsidiary
Familiarisation Programme
Whistle Blower Policy
Composition of Committees
ISL-NCLT Petition
Annexure i to xii of Petition
Annexure xiii-list of Depositors
List Of FD Holders
Annexure xiv to xvi of Petition
Advertisement
Why Choose Us
Our Presence
Strengths
Ranking
Awards
Production
Major Break Throughs
Products In Pipeline
Major Break Throughs
Ind-Swift has filed more than 680 dossiers for registration in more than 20 Countries around the world stretching from South America to Philippines.
It has developed Netazoxanide Anti-Diarrheal drug for the first time in India after successful clinical trials and bio-equivalence studies.
It has strong capacity to develop non infringing API's requiring Complex Chemistry and Multiple reactions.
Ind-Swift has developed taste masking technology of macrolides for the first time in India.
Ind-Swift has developed the sustained release process of Isoxsuprine HCL tablets for the first time in India.
Ind-Swift has developed the dissolving tablet technique.
Ind-Swift has filed more than 680 dossiers for registration in more than 20 Countries around the world stretching from South America to Philippines. 